| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ADAMTS19
|
ADAM metallopeptidase with thrombospondin type 1 motif, 19
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
AR
|
androgen receptor
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRSK1
|
BR serine/threonine kinase 1
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CYB561
|
cytochrome b561
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXE1
|
forkhead box E1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
GDF9
|
growth differentiation factor 9
|
|
HK3
|
hexokinase 3 (white cell)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
INHA
|
inhibin, alpha
|
|
KDR
|
kinase insert domain receptor
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
MIR1468
|
microRNA 1468
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR518C
|
microRNA 518c
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYADML
|
myeloid-associated differentiation marker-like (pseudogene)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRXN1
|
neurexin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PRLR
|
prolactin receptor
|
|
RAN
|
RAN, member RAS oncogene family
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SF1
|
splicing factor 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SOHLH2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2
|
|
SYCE1
|
synaptonemal complex central element protein 1
|
|
TG
|
thyroglobulin
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGIF2LX
|
TGFB-induced factor homeobox 2-like, X-linked
|
|
TNF
|
tumor necrosis factor
|
|
TYMS
|
thymidylate synthetase
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
XPO5
|
exportin 5
|
